The advertisement promotes Repatha (evolocumab) for very high-risk ASCVD patients, emphasizing the need for LDL-C management and adherence to the 2022 ACC ECDP recommendations.
Creative Information
| CID: | 0636def7-bf96-4b6f-8059-07757bf1124a |
| CRID: | 89_188124 |
| Domain: | repatha.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $1.50 |
| Timestamp: | 11/18/2025, 8:31:27 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 9:15:00 PM | 7.34s | |
| adomain_analysis | success | 11/18/2025, 10:38:08 PM | 3.73s | |
| adomain_capture | success | 11/18/2025, 10:38:04 PM | 0.43s | |
| ad_render | success | 11/18/2025, 9:14:52 PM | 26.78s | |
| brand_mapping | success | 11/18/2025, 8:31:27 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: Repatha
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1537.50 KB | ||||||||||||||||||||||
| Render Time: | 8.96 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1537.58 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


